| Anthrax Arboviral diseases, neuroinvasive and nonneuroinvasive†
Babesiosis Botulism
Brucellosis Campylobacteriosis† Chancroid Chlamydia trachomatis infection Cholera (toxigenic Vibrio cholerae O1 or O139) Coccidioidomycosis Cryptosporidiosis Cyclosporiasis Dengue virus infections†
Diphtheria Ehrlichiosis and anaplasmosis
Giardiasis Gonorrhea Haemophilus influenzae, invasive disease† Hansen’s disease (Leprosy) Hantavirus infection, non-Hantavirus pulmonary syndrome† Hantavirus pulmonary syndrome† Hemolytic uremic syndrome, postdiarrheal Hepatitis viral infections
HIV diagnoses§ Influenza-associated pediatric mortality Invasive pneumococcal disease (Streptococcus pneumoniae, invasive disease) Legionellosis Leptospirosis Listeriosis Lyme disease
|
Malaria Measles Meningococcal disease (Neisseria meningitidis)† Mumps Novel influenza A virus infections Pertussis Plague Poliomyelitis, paralytic Poliovirus infection, nonparalytic Psittacosis Q fever
Rabies
Rubella Rubella, congenital syndrome Salmonellosis Severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV) Shiga toxin-producing Escherichia coli (STEC) Shigellosis Smallpox Spotted fever rickettsiosis Streptococcal toxic shock syndrome Syphilis¶
Tetanus Toxic shock syndrome (other than streptococcal) Trichinellosis Tuberculosis Tularemia Typhoid fever (caused by Salmonella enterica serotype typhi) Vancomycin-intermediate Staphylococcus aureus (VISA) infection Vancomycin-resistant Staphylococcus aureus (VRSA) infection Varicella (morbidity) Varicella (mortality) Vibriosis (any species of the family Vibrionaceae, other than toxigenic Vibrio cholerae O1 or O139) Viral hemorrhagic fever**
Yellow fever |
* This list reflects position statements approved in 2014 by CSTE for national surveillance, which were implemented in January 2015. National surveillance case definitions for these infectious diseases and conditions are available at https://wwwn.cdc.gov/nndss/conditions.
† Campylobacteriosis, Chikungunya virus disease (neuroinvasive and nonneuroinvasive), and Hantavirus infection, non-Hantavirus pulmonary syndrome were added to the notifiable disease list in 2015. For the other specified conditions, the year 2015 reflects a modified surveillance case definition for the specified diseases, as per approved 2014 CSTE position statements.
§ AIDS (Acquired Immunodeficiency Syndrome) has been reclassified as HIV stage III.
¶ Includes the following categories: primary, secondary, latent (including early latent and late latent), and late syphilis with clinical manifestations (including late benign syphilis and cardiovascular syphilis).
**As of January 1, 2015, the event code for Viral Hemorrhagic Fevers (VHF) was retired and new event codes were used to report disease-specific VHF cases.
For more information on these diseases click here: https://www.cdc.gov/mmwr/volumes/64/wr/mm6453a1.htm?s_cid=mm6453a1_w